[Bevacizumab therapy for a colorectal cancer patient or hemodialysis with hepatic metastasis].
Gan To Kagaku Ryoho
; 40(5): 647-50, 2013 May.
Article
en Ja
| MEDLINE
| ID: mdl-23863592
ABSTRACT
We report our experience with a case of colorectal cancer treated with chemotherapy for a liver metastasis patient on hemodialysis. The patient was a 67-year-old man with a history of chronic renal failure, who was on hemodialysis since 2005. High anterior resection was performed for sigmoid colon and rectal cancer in January, 2010. After starting chemotherapy while planning to use FOLFOX6+bevacizumab(BV)as a postoperative standard chemotherapy, in combination with hemodialysis three times a week while performing dose escalation, administration postponement was continued for myelosuppression that was considered to be the effect of oxaliplatin. Oxaliplatin was administered for only 2 courses, and was then changed to BV+sLV5FU2 therapy. We continued treating the metastases approximately on schedule. Imaging revealed, the liver metastases were CR because they had disappeared. The BV use case of the dialysis case had few reports, but was thought to be able to use it by careful administration safely.
Buscar en Google
Bases de datos:
MEDLINE
Asunto principal:
Neoplasias del Colon Sigmoide
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Neoplasias Hepáticas
Límite:
Aged
/
Humans
/
Male
Idioma:
Ja
Revista:
Gan To Kagaku Ryoho
Año:
2013
Tipo del documento:
Article
País de afiliación:
Japón